End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
780,000 KRW | -1.27% | -1.27% | +2.63% |
Apr. 25 | Samsung Bioepis Granted Approval to Market Autoimmune Treatment in Europe | MT |
Apr. 25 | Samsung Biologics Posts Higher Q1 Profit, Sales | MT |
- Stock Market
- Equities
- A207940 Stock
- News Samsung Biologics Co.,Ltd.